Original Articles The Prevalence of Cardiovascular Abnormalities in Thyrotoxicosis - A Cross Sectional Study

Background: In this Cross sectional study over a period of one year, conducted in the Division of Cardiology, Dept. of Medicine, Govt. Medical College Hospital Jammu, a total of 50 cases were studied for cardiovascular abnormalities occurring in thyrotoxicosis. Aims: We investigated the prevalence and clinical importance of cardiovascular abnormalities in patience with thyrotoxicosis. Settings and Design: This is a cross sectional study conducted over a period of one year in a tertiary care hospital offering specialty and super specialty including cardiology. We studied 50 cases of whom 11 were males and 39 were females. The study covered age group with a range of 16 years to 85 years. Methods and Material: All newly diagnosed cased of thyrotoxicosis were included in the study and were evaluated on a protocol which includes: history, general physical examination, cardiovascular examination and investigation: bio chemical profile, hormonal assay, chest radiography, twelve – lead electrocardiogram (ECG), Echocardiography (ECHO) (M-Mode/2 dimensional/Colour Doppler). Statistical Analysis: Descriptive analysis including calculation of percentages as deemed fit for qualitative variables. For quantitative variables, mean and standard deviation were calculated and reported. Results: 50 patients (Mean [+/- SD] age, 45.7 yrs, range 16-85 yrs; 78% females) were included. Weakness and fatigability was present in every patient (100%), followed by palpitation, shortness of breath and weight loss (94%). We found ventricular hypertrophy (40%), congestive heart failure (CHF) (36%), cardiomegaly (24%), arrhythmias (24%) and bundle branch block (18%) of the patients. Conclusion: Cardiovascular abnormalities in thyrotoxicosis should never be over looked, prognosis and outcome of the heart disease depends on early institution of treatment and control of the hormone levels.

[1]  S. Krishnamoorthy,et al.  Unusual presentation of thyrotoxicosis as complete heart block and renal failure: a case report , 2009, Journal of medical case reports.

[2]  D. Singer,et al.  Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators , 2009, Stroke.

[3]  I. Klein,et al.  Thyroid disease and the heart. , 2007, Circulation.

[4]  C. Lau,et al.  Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism , 2006, Heart.

[5]  S. Bhadada,et al.  Juvenile hyperthyroidism: an experience. , 2006, Indian pediatrics.

[6]  A. Bardají,et al.  Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. , 2005, The American journal of medicine.

[7]  J. Auer,et al.  Subclinical hyperthyroidism as a risk factor for atrial fibrillation. , 2001, American heart journal.

[8]  S. Masoodi,et al.  Clinical and endocrine aspects of thyrotoxicosis and its cardiovascular complications. , 2000, Annals of Saudi medicine.

[9]  D. Freimark,et al.  Unstable anginal syndrome and pulmonary oedema due to thyrotoxicosis. , 1991, Postgraduate medical journal.

[10]  Morgan Hj,et al.  A Reversible Cardiomyopathy , 1989 .

[11]  A. Toft,et al.  CARDIOVASCULAR RESPONSES IN HYPERTHYROIDISM BEFORE AND DURING 0‐ADRENOCEPTOR BLOCKADE: EVIDENCE AGAINST ADRENERGIC HYPERSENSITIVITY , 1982, Clinical endocrinology.

[12]  C. Symons Thyroid heart disease. , 1979, British heart journal.

[13]  L. Papadaki,et al.  Cardiovascular effects of thyroxine. , 1969, Cardiovascular research.

[14]  G. Sandler,et al.  The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I. , 1959, The Quarterly journal of medicine.

[15]  G. Gordan,et al.  ELECTROCARDIOGRAPHIC FEATURES ASSOCIATED WITH HYPERTHYROIDISM , 1944 .

[16]  S. Surtees,et al.  THYROTOXICOSIS AND HEART DISEASE , 1936, British medical journal.